These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1826136)

  • 1. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.
    Steinberg KK; Thacker SB; Smith SJ; Stroup DF; Zack MM; Flanders WD; Berkelman RL
    JAMA; 1991 Apr; 265(15):1985-90. PubMed ID: 1826136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal estrogen replacement therapy and breast cancer.
    Dupont WD; Page DL
    Arch Intern Med; 1991 Jan; 151(1):67-72. PubMed ID: 1824675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women.
    Colditz GA; Stampfer MJ; Willett WC; Hennekens CH; Rosner B; Speizer FE
    JAMA; 1990 Nov; 264(20):2648-53. PubMed ID: 2232041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The postmenopausal estrogen/breast cancer controversy.
    Henrich JB
    JAMA; 1992 Oct; 268(14):1900-2. PubMed ID: 1404715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
    Persson I; Yuen J; Bergkvist L; Schairer C
    Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormone therapy and the risk of breast cancer in Norway.
    Román M; Sakshaug S; Graff-Iversen S; Vangen S; Weiderpass E; Ursin G; Hofvind S
    Int J Cancer; 2016 Feb; 138(3):584-93. PubMed ID: 26289549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies.
    Pizot C; Boniol M; Mullie P; Koechlin A; Boniol M; Boyle P; Autier P
    Eur J Cancer; 2016 Jan; 52():138-54. PubMed ID: 26687833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone replacement therapy and breast cancer: a meta-analysis.
    Sillero-Arenas M; Delgado-Rodriguez M; Rodigues-Canteras R; Bueno-Cavanillas A; Galvez-Vargas R
    Obstet Gynecol; 1992 Feb; 79(2):286-94. PubMed ID: 1530988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone replacement therapy in menopause and risk of breast cancer].
    Fournier A; Hill C; Clavel-Chapelon F
    Bull Cancer; 2003 Oct; 90(10):821-31. PubMed ID: 14706912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.